The study presented herein was designed to test the hypothesis that reduced endogenous estrogen in the boar alters efferent duct morphology, epididymal morphology, and steroid receptor expression. Twenty-eight littermate pairs of boars were treated with Letrozole, an aromatase inhibitor, or with vehicle from 1 week of age until castration at 2 through 8 months. Efferent ducts and epididymides were examined for morphological development and steroid receptor expression. Efferent duct morphology was not different between control and Letrozole-treated animals at any examined age. Androgen receptor (AR), estrogen receptor a (ERa), and b (ERb) were expressed in the epithelial cells of the efferent ducts at all ages; expression was similar in control and treated animals. Morphological development of the caput and corpus was delayed in Letrozole-treated animals, but this delay was transient since morphology was similar between control and treated animals at 8 months. The cauda did not show a delay in development, but was more developed in treated animals at 2 months. AR, ERa, and ERb were expressed in all three epididymal regions; no difference was observed between control and treated animals. In summary, estrogen appears to be important for development of the epididymis; however, the cauda may be regulated differently than the caput and corpus. Results for the efferent ducts suggest that the normally high endogenous estrogens are not required for regulation of fluid reabsorption in the boar. It also suggests that any ER activation required for maintenance of efferent duct morphology and function is normal in Letrozole-treated boars.
Introduction
Efferent duct and epididymal function are androgen dependent (Ezer & Robaire 2002) . Androgens are required for maintenance of epithelial morphology (Ezer & Robaire 2002) , protein secretion (Syntin et al. 1999) , and regulation of the androgen receptor (AR; Zhu et al. 2000) . Recent evidence, however, has demonstrated that estrogen is important for function of the efferent ducts (Hess & Carnes 2004) . The efferent ducts of estrogen receptor alpha knockout (aERKO) mice fail to properly reabsorb fluid from the testes leading to testicular atrophy and infertility (Hess et al. 1997) . Mice and rats treated with ICI 182 780 (ICI), an ER antagonist, also failed to properly reabsorb fluid from the lumen of the efferent ducts demonstrating that the infertility of aERKO mice is due to the lack of ER action, rather than developmental problems (Lee et al. 2000 , Oliveira et al. 2001 , Cho et al. 2003 . In contrast to aERKO mice, aromatase knockout (ARKO) mice, did not exhibit impaired fluid reabsorption in the efferent ductules (Robertson et al. 1999 , O'Donnell et al. 2001 ). Estrogen appears to mediate fluid reabsorption by regulating the expression of ion transporters such as the sodium/hydrogen exchanger-3 , Zhou et al. 2001 and aquaporins (Oliveira et al. 2005) involved in water movement. The physiological basis for differences between the aERKO and ARKO models is still unclear although recent work suggests ER activation is a critical difference.
Recent evidence suggests that estrogen may regulate epididymal function. Cauda sperm numbers in both aERKO and ICI treated mice were reduced and the sperm had reduced motility and fertilizing ability (Cho et al. 2003) . ICI treated mice had epididymal abnormalities in addition to reduced sperm fertility (Cho et al. 2003) . Bonnet monkeys treated with ICI had reduced sperm motility but, in contrast to mice, sperm numbers were similar between control and treated animals (Shayu et al. 2005) . These results suggest that epididymal function is directly affected by inhibiting the actions of estrogen in these males with relatively low endogenous estrogen. Current understanding of efferent duct/epididymal development derives primarily from rodent models. While a few studies have described the morphology of the mature boar efferent ducts and epididymis (Stoffel et al. 1991 , Stoffel & Friess 1994 , none have characterized the development of the boar efferent ducts or epididymis, a male with relatively high endogenous estrogens, or investigated how the porcine epididymis is regulated by steroid hormones.
Estrogens and androgens exert their effects by binding to specific receptors in the target tissue. Both ERa and ERb, in addition to AR, are expressed in cells from the efferent ducts to the cauda in numerous species, although differences exist in regional localization (Hess & Carnes 2004) . AR and ERb have been localized to the epithelium of the efferent ducts and all three regions of the adult epididymis in numerous species (Nie et al. 2002 , Yamashita 2004 , Parlevliet et al. 2006 , including the pig . ERa is expressed in the efferent ducts of all species studied but epididymal expression is much more variable among species (Hess & Carnes 2004 ) and even within a species like the horse (Parlevliet et al. 2006) . The developmental profile of morphology and steroid regulation of AR, ERa, and ERb expression in the efferent ducts and epididymis of the boar is unknown. Given the variation that exists among species, detailing the localization of ERs and AR in the boar is important before conclusions are reached about the role of estrogens in the epididymis and efferent ducts of this male with high endogenous estrogen levels.
Studies on the physiological effects of estrogen have been facilitated by the development of specific inhibitors of aromatase, the enzyme responsible for estrogen synthesis. Aromatase in the boar is found primarily in the Leydig cells of the testis (Conley et al. 1996 , Mutembei et al. 2005 and estrogen is delivered to the efferent ducts and epididymis through the tubules or via the blood. Circulating estrogen concentrations in the boar (w200 pg/ml) are relatively high compared with males of other species (2-50 pg/ml; Ford 1983 , Hess & Carnes 2004 . Our laboratories have previously demonstrated that treatment with Letrozole, an aromatase inhibitor, significantly reduces aromatase activity in the boar testis leading to reduced testicular and systemic estrogen concentrations without changing testosterone or gonadotropin concentrations (At-Taras et al. 2006a) . This is an important feature of our model as aERKO mice have increased testosterone and gonadotropin concentration, and ARKO mice have increased testosterone and luteinizing hormone (LH) concentrations (O'Donnell et al. 2001) . Boars treated weekly with Letrozole throughout their life showed a delayed testicular development but at 8 months, testis size and total sperm production were increased (At-Taras et al. 2006b ). Cauda epididymal sperm numbers were reduced in these boars (McCarthy et al. 2006 ) even though testis size and sperm production were increased. In vitro fertilizing ability of cauda epididymal sperm was reduced in Letrozole-treated animals compared with control animals at 6 and 7 months but was similar at 8 months (McCarthy et al. 2006) . Other sperm parameters such as percentage of motile sperm, head morphology, and the ability to undergo the acrosome reaction were unaffected by treatment. The initial reduction in cauda sperm fertilizing ability and sperm numbers suggests that reducing endogenous estrogen may affect efferent duct and epididymal development and function in the boar; however, this was not examined in our previous reports.
Here we investigate the effects of reduced endogenous estrogen production on the efferent ducts and epididymis in Letrozole-treated boars. It was hypothesized that reduced endogenous estrogen production would alter efferent duct and epididymal development and steroid receptor expression. To test this hypothesis, the efferent ducts and epididymis of control and Letrozole-treated boars were examined for changes in morphology and steroid receptor expression.
Results

Morphology
The tubule diameter, lumen diameter, and epithelial cell height of the efferent ducts in control boars were 67G29 mm, 43G27 mm, and 12G2 mm respectively, at 2 months of age and increased to 205G28 mm (P!0.0001), 147G26 mm (PZ0.0001), and 21G2 mm (PZ0.02) respectively, at 5 months of age without further increase at 8 months (Fig. 1) . No differences were seen in tubule diameter, lumen diameter, or epithelial height of efferent ducts between control and Letrozole-treated animals ( Fig. 1) .
In the caput (Fig. 2) , tubule and lumen diameter of control animals significantly increased from 2 to 5 months (P!0.0001) without further significant increases at 8 months. In treated animals, tubule diameter increased between 2 and 5 months (P!0.0001) and further increased between 5 and 8 months (PZ0.0002); lumen diameter did not increase between 2 and 5 months but did increase between 5 and 8 months in treated boars (PZ0.004). Tubule and lumen diameter were similar between control and Letrozole-treated animals except at 5 months when the tubule and lumen diameters were smaller in treated animals (P%0.002). Epithelial height significantly increased from 2 to 5 months (P!0.0001), without further increases at 8 months in both control and Letrozoletreated animals. Epithelial height was not different between control and treated animals at any age.
In the corpus (Fig. 3) , tubule and lumen diameter of control animals significantly increased from 2 to 5 months (P!0.0001) without further significant increases at 8 months. In treated animals, tubule and lumen diameter increased between 2 and 5 months (P%0.018) and further increased between 5 and 8 months (P%0.017). Epithelial height significantly increased from 2 to 5 months (P!0.0001), without further increases at 8 months in both control and Letrozole-treated animals. Tubule diameter, lumen diameter, and epithelial height were similar between control and Letrozole-treated animals at all ages.
In the cauda (Fig. 4) , tubule and luminal diameter significantly increased from 2 to 5 months in control (P!0.0001) and treated (P%0.046) animals without further significant increases at 8 months. Epithelial height did not increase with age in the cauda in either control or Letrozole-treated animals (PO0.5). Tubule diameter, lumen diameter, and epithelial height were similar between control and Letrozole-treated animals except at 2 months when the tubule diameter (P!0.0001), lumen diameter (P!0.0001), and epithelial height (P!0.04) were increased in treated animals.
Paired epididymal weight increased from 8.10G0.7 g at 2 months of age to 153.8G9.8 g at 8 months of age in control animals (P!0.0001). Epididymal weights were similar between control and treated animals ( Fig. 5 ) except at 7 months of age when the weight was increased in control animals (PZ0.005).
Steroid concentrations
Our previous reports show that testicular aromatase activity was reduced by 83% overall in Letrozole-treated boars with a 92% reduction at 2 months of age (168.1G16.5 pmol (mg/protein)/h in control boars versus 16.5 pmol (mg/protein)/h in treated boars) (At-Taras et al. 2006a) . Testicular and systemic concentrations of estradiol were significantly reduced in Letrozole-treated boars; however, testosterone concentrations were unchanged (At-Taras et al. 2006a) . Here we report the concentrations of estradiol and testosterone in the efferent ducts and epididymis of these Letrozole-treated boars. Estradiol concentrations were decreased in the efferent ducts and epididymis of Letrozole-treated animals compared with control animals throughout development (Table 1 ; data from 2 and 8 months presented). In control animals, the concentration of estradiol in the efferent ducts was higher than the epididymis at 2 months (P!0.05) but this was not observed in other age groups. Concentrations were similar among the epididymal regions with no gradient of increasing or decreasing estradiol concentrations observed in control or Letrozole-treated boars. Estradiol concentrations in the efferent ducts were highest at 2 months (P!0.05); no differences were observed in the concentrations of estradiol in the epididymis with age (PO0.05).
Testosterone concentrations were similar between control and Letrozole-treated animals in the efferent ducts and epididymis throughout development except in the caput at 2 months (Table 1 ; data from 2 and 8 months presented). The concentration of testosterone in the efferent ducts was not different from the epididymis in control and Letrozole-treated animals. Concentrations were similar among the epididymal regions with no overall gradient of increasing or decreasing testosterone concentrations observed in control or Letrozole-treated boars. No differences were observed in the concentrations of testosterone in the efferent ducts or epididymis with age (PO0.05). An increase with age was observed in tubule and lumen diameter in both control and treated boars. Tubule diameter, lumen diameter, and epithelial height were increased at 2 months of age in treated animals. LSMeansGpooled S.E.M. of untransformed data is presented; statistics were performed on log-transformed data. a versus b (control), P!0.0001; A versus B (treated), P!0.05. *(control versus treated), P%0.04.
Steroid receptor localization
The epithelial cells of the efferent ducts were positive for AR, ERa, and ERb ( Fig. 6 ) throughout development in control animals; no age differences were observed. Immunostaining for AR, ERa, and ERb was similar between control and Letrozole-treated boars in the efferent ducts. Negative controls incubated with NRS (AR and ERa) or mouse IgG (ERb) instead of primary antibody did not exhibit immunostaining.
At 2 months, AR was present in the epithelial cell nuclei of the caput, corpus, and cauda and continued to be present in the nuclei of principal and basal cells of the caput, corpus, and cauda from 3 to 8 months (Fig. 7) . No age difference was seen in AR immunostaining. Intermittent immunostaining of smooth muscle was also seen in all three regions throughout development. Immunostaining for AR was similar between control and Letrozole-treated boars in the epididymis.
At 2 months, ERa was present in most epithelial cell nuclei of the caput, corpus, and cauda and continued to be present in the nuclei of principal and basal cells of the caput, corpus, and cauda from 3 to 8 months (Fig. 8) . However, at 8 months of age, fewer cells were positive in the corpus and cauda compared with younger boars. Immunostaining for ERa was similar between control and Letrozole-treated boars in the epididymis.
At 2 months, ERb was present in the epithelial cell nuclei of the caput, corpus, and cauda and continued to be present in the nuclei of principal and basal cells of the caput, corpus, and cauda from 3 to 8 months (Fig. 9 ). No age difference was observed in ERb immunostaining. Immunostaining for ERb was similar between control and Letrozole-treated boars in the epididymis.
Steroid receptor mRNA
ERa mRNA in the efferent ducts of treated animals was 9-fold higher (P!0.05) than control animals at 2 months and was 38-fold higher (P!0.005) than control animals at 8 months (Fig. 10) . However, this difference in mRNA did not correlate with protein levels as ERa protein in the efferent ducts at 8 months was similar between control and Letrozole-treated animals as determined by Western blot analysis (Fig. 11) . ERa mRNA was unchanged in caput and cauda but was eightfold less in the corpus of 2-month treated animals compared with control animals (P!0.05). Significant differences were not observed in ERa mRNA in the caput, corpus, or cauda of treated animals at 8 months, nor were significant differences observed in AR or ERb mRNA in the epididymis or efferent ducts of treated animals at 2 or 8 months (data not shown).
Discussion
Previously, we reported that boars treated weekly with Letrozole have reduced testicular and circulating concentrations of estrogens without changes in testosterone or gonadotropin (LH and follicle-stimulating hormone) concentrations (At-Taras et al. 2006a ). This contrasts with the aERKO and ARKO mouse models in which testosterone and gonadotropin concentrations are increased (O'Donnell et al. 2001 ). Here we demonstrate that estrogen concentrations are also reduced in the efferent ducts and epididymis of Letrozole-treated boars. Cauda epididymal sperm numbers were reduced in Letrozole-treated boars at 8 months of age (McCarthy et al. 2006 ) even though testis size and hence total sperm production were increased (At-Taras et al. 2006b ). Here we report the effects of reduced endogenous estrogen on the efferent ducts and epididymis in these boars. To our knowledge, this is the first report describing the development of the efferent ducts in boars and to evaluate the role of estrogen in this process. The efferent ducts, whose primary function is fluid reabsorption, connect the rete testis to the epididymis and consist of principal and ciliated cells (Stoffel & Friess 1994) . In this study, tubule diameter, lumen diameter, and epithelial height of the efferent ducts increased from 2 to 5 months without further increases up to 8 months in both control and treated animals. The tubule diameter and epithelial heights at 8 months reported here are similar to previously reported values for mature boar efferent ducts (Stoffel & Friess 1994) . Puberty occurs between 4 and 5 months in boars, therefore, it is not surprising to see morphological changes occurring during this time when fluid and sperm first begin to enter the efferent ducts. Previous studies in aERKO mice have demonstrated that inhibition of estrogen action leads to impaired fluid reabsorption by the efferent ducts resulting in increased lumen diameter and decreased epithelial height (Lee et al. 2000) . ARKO mice, however, do not show these same defects of efferent duct function (Robertson et al. 1999) . In the present study, tubule diameter, luminal diameter, and epithelial height were similar between control and Letrozole-treated boars at all ages examined. It is possible that a threshold level of estradiol is needed to maintain normal efferent duct morphology and function and that treated boars, while having significantly reduced estradiol concentrations, were still above that threshold. Results presented here for boars are similar to the results found in ARKO mice, which do not show abnormal efferent ducts under the complete elimination of estrogen. Estrogen, acting through its receptors, appears to mediate fluid reabsorption in the mouse efferent duct by regulating the expression of ion transporters , Zhou et al. 2001 involved in water movement such as the sodium/hydrogen exchanger-3 (NHE3) and aquaporins (Oliveira et al. 2005) . However, efferent duct expression of ERa, ERb, and AR protein was similar between control and treated boars in this study. Proteins and ion channels involved in water movement may be either constitutively expressed or regulated by androgens or other testicular factors in addition to estrogens in the boar. ERa was reported to be activated in the absence of estrogen by other factors like EGF (Coleman & Smith 2001 , Marquez et al. 2001 . Aquaporin-1 is constitutively expressed and aquaporin-9 is regulated by both estrogen and DHT in the rat efferent ducts (Oliveira et al. 2005) . Recently, 5a-androstane-3b,17b-diol (3-betadiol), a dihydrotestosterone (DHT) metabolite was also found to restore aquaporin-9 expression after castration, similar to DHT and estradiol (Picciarelli-Lima et al. 2006) . This 3-beta-diol bound to both ERa and ERb with a higher affinity for ERb (Kuiper et al. 1997) . Furthermore, the estrogen response element in genes of the ARKO mouse was functional (Hayashi et al. 2006) despite the absence of estrogen. If ERa and ERb are activated by 3-beta-diol or other ligands that were unaltered by treatment, then the downstream effects of these receptors on aquaporins and ion transporters, like NHE3, would be unaffected. These results suggest that the regulation of fluid reabsorption in the efferent ducts of boars does not require estrogen similar to the ARKO mouse. Activation of ERs is blocked in ERKO mice, but likely remains intact in Letrozole-treated boars and ARKO mice. Maintenance of efferent duct development during aromatase inhibition supports the hypothesis developed from the ARKO model that ER activation rather than estrogen itself is required for normal efferent duct development. Therefore, it is possible that ER activation under reduced estrogen conditions is maintained by other ligands in the efferent ducts and this could explain the differences between the Letrozoletreated boars or ARKO mice and the aERKO mice. AR expression was similar between control and Letrozole-treated boars as anticipated, since testosterone concentrations were similar in control and Letrozoletreated boars. Expression of ERa and ERb protein was similar between control and Letrozole-treated boars despite the differences in estradiol concentrations. ERa mRNA in the efferent ducts of treated boars was increased relative to controls at 2 and 8 months but this was not accompanied by a corresponding increase in ERa protein. A similar result was found for ERa in 30-day-old ICI treated bonnet monkeys (Shayu et al. 2005) . Protein turnover of ERa may be higher in the efferent duct of Letrozole-treated boars. In contrast to ERa, ERb mRNA in treated animals was not altered relative to control animals suggesting that ERa and ERb protein expression in the boar efferent ducts are regulated differently and possibly by factors other than estrogen. Testosterone was reported to regulate ER expression during development in the rabbit epididymis (Toney & Danzo 1988) and can upregulate ERb in the rat prostrate (Asano et al. 2003) . DHT increased ERb expression in the endometrium of gilts (Cardenas & Pope 2005) . Therefore, ERa and ERb expressions in the boar efferent ducts may be regulated by androgens.
In control and Letrozole-treated animals, tubule and lumen diameter increased with age in all three epididymal regions, while epithelial height increased with age in the caput and corpus. The smaller tubule and lumen diameter in the caput and corpus at 5 months in treated animals followed by significant increases between 5 and 8 months suggests a delay in development of these regions as a result of reduced endogenous estrogen. The delay was transient, however, as tubule and lumen diameters were similar between control and Letrozole-treated animals at 8 months. Values reported here for 8-month animals are similar to values previously reported for mature boars (Stoffel & Friess 1994) . In both control and treated animals, tubule and lumen diameter increase from caput to cauda at 8 months while epithelial height decreases from caput to cauda. This pattern from caput to cauda is similar to previous reports for the boar (Stoffel & Friess 1994 ) and other species (Goyal 1985 , Goyal & Williams 1991 , Calvo et al. 1999 .
The delay in development may be a direct result of decreased estrogen stimulation or the result of decreased signaling from other testicular factors and sperm. A delay in testicular development was also observed in these Letrozole-treated boars (At-Taras et al. 2006b ). This delay resulted in fewer sperm in the epididymis and perhaps other testicular factors that may be involved in epididymal development during puberty. Luminal fluid factors from the testis play a role in epididymal development (Rodriguez et al. 2002) and it is possible that the caput and corpus require these factors for tubule expansion and epithelial differentiation. A delay in development was not observed in the cauda; in contrast, tubule diameter, lumen diameter, and epithelial height were increased at 2 months of age. These results suggest that the cauda is regulated differentially than the caput and corpus during development and may be less dependent on testicular factors.
Epididymal weight increased with age and was similar between control and Letrozole-treated animals, except at 7 months when it was significantly less. Morphology of the caput, corpus, and cauda at 7 months was similar between control and Letrozole-treated boars. Our labs have previously reported significantly reduced sperm numbers in the cauda epididymis of Letrozole-treated boars at 7 months (McCarthy et al. 2006 ) and this likely accounts for the difference in epididymal weight. Sperm numbers were still reduced at 8 months, although not as severely as at 7 months. The lack of difference in epididymal weight at 8 months supports the hypothesis that the effect of Letrozole treatment on sperm numbers is transient and recovering at 8 months.
The localization of ERa, ERb, and AR in the epididymis of mature animals has been reported for numerous species; however, the expression of these receptors throughout development has been described in only a few species. In this study ERa, ERb, and AR were expressed in the caput, corpus, and cauda of the boar from 2 to 8 months of age. No difference was seen in the epididymis between control and Letrozole-treated animals for ERa, ERb, or AR. Since estradiol concentrations were significantly reduced in treated animals, ERa and ERb in the epididymis may be regulated by androgens or other testicular factors that were not altered by treatment. The developmental expression pattern reported here is consistent with results found for AR and ERb in other species (Goyal et al. 1997a , Atanassova et al. 2001 , Nie et al. 2002 , Yamashita 2004 , Parlevliet et al. 2006 including the mature boar (Carpino et al. 2004 . Although the immature boar epididymis was previously reported to be negative for ERb (Carpino et al. 2004 ), our results demonstrate that ERb is expressed in the boar epididymis throughout development. In most species, including the newborn pig, ERa was localized only to the efferent ducts while the epididymis is negative (Fisher et al. 1997 , Goyal et al. 1997b , Nielsen et al. 2001 , Nie et al. 2002 , Hess & Carnes 2004 . In this study, ERa was localized to all three regions with fewer cells being positive in the corpus and cauda of 8 month animals as is the case in the mature boar, in which the corpus has only a few positive cells and the cauda is negative . This suggests that estrogenic effects mediated through ERa in the cauda are necessary during development but not for mature function. The expression of ERa, ERb, and AR protein reported here suggests that estrogen, in addition to androgen, has a role throughout the development of the boar epididymis. The delay in development observed in our treated animals also suggests that estrogen is important for development in the boar but the mechanism by which estrogen acts requires further investigation.
In conclusion, ERs and ARs were expressed in the efferent ducts and all three epididymal regions throughout development suggesting that these tissues may be regulated by both estrogens and androgens in the boar. The lack of difference in receptor expression for ERa and ERb suggests that ER expression in the boar efferent ducts and epididymis may be regulated by factors other than estrogen. Morphological development of the epididymis was delayed in Letrozole-treated boars suggesting that estrogen, directly or indirectly, affects normal morphological development of the epididymis. Efferent duct morphology and ER protein expression were unaffected by Letrozole treatment suggesting that the normally high endogenous levels of estradiol are not required for regulation of fluid reabsorption. If ER activation is important for regulation of fluid reabsorption in the porcine efferent ducts, receptor activation can be maintained in the absence of normal physiological levels of estradiol. This could explain why the efferent duct phenotype of Letrozole-treated boars in this study, which has similarities to ARKO mice, differs from the phenotype of aERKO mice.
Materials and Methods
Animal treatment and tissue collection
Twenty-eight littermate pairs of boars were treated orally with either vehicle (corn oil) or with a nonsteroidal aromatase inhibitor (0.1 mg/kg bodyweight Letrozole; CGS 20267; 4-4 0 -(1H-1,2,3-triazol-1-yl-methylene)-bis-benzonitrile; CibaGeigy, Basel, Switzerland) once a week starting at 1 week of age until castration at 2-7, or 8 months (At-Taras et al. 2006a , 2006b ). This study was conducted in accordance with the Guide for the Care and Use of Agricultural Animals in Agricultural Research and Teaching and approved by the Animal Use and Care Advisory Committee at the University of California at Davis. Boars were from established lines developed from Durocs, Hampshires, Yorkshires, and Pietrains provided by PIC USA (a division of Sygen International, Franklin, KY, USA) and housed at the UC Davis swine facility. Testicular aromatase activity, testicular steroid concentrations, and systemic steroid concentrations for these animals have previously been reported (At-Taras et al. 2006a) .
Four littermate pairs (nZ4 control and nZ4 treated) were castrated at each age; efferent ducts and epididymides were collected at castration. Epididymides were divided into three regions (caput, corpus, and cauda) based on previous studies (Syntin et al. 1996 (Syntin et al. , 1999 . Portions of efferent ducts and each epididymal region were fixed in 4% paraformaldehyde for immunocytochemistry (ICC) and morphology measurements or snap frozen in liquid nitrogen and stored at K80 8C until processing for determination of steroid concentrations and mRNA quantification.
Steroid concentrations
Samples (0.5-1 g) were thawed at room temperature and minced into small pieces (w1 mm 3 ). Minced tissue was homogenized in 2 ml PBS for 1.5-2 min (Barnant Mixer, series 10, Chicago, IL, USA). The homogenate was centrifuged at 2271 g (Sorvall RT600B; Dupont; Wilmington, DE, USA) for 15 min; the supernate was centrifuged again at 13 500 g (MiniSpin plus; Eppendorf, Westbury, NY, USA) for 15 min to remove any remaining unhomogenized tissue. The final supernate was stored at K20 8C until analysis for testosterone, estradiol, and total protein concentration. (Fisher Scientific, Pittsburgh, PA, USA) ; extraction efficiency was 90%. Assay sensitivity was 0.1 ng/ml. Intra-and inter-assay coefficients of variation were 5.4% (nZ6) and 13.1% (nZ5) respectively.
Estradiol-17b (E 2 )
Epididymal tissue concentrations of E 2 were determined using a RIA previously validated for the pig (At-Taras et al. 2006a) . The RIA used a sheep anti-estradiol 17b-6-BSA antibody (Niswender no. 224), 3 H-E 2 (Perkin-Elmer Life Sciences, NET-317), and estradiol standards (E950; Steraloids). Samples were extracted with ethyl ether (Fisher Scientific) ; extraction efficiency was 90%. Assay sensitivity was 6.25 pg/ml. Intra-and inter-assay coefficients of variation were 6.0% (nZ6) and 13.3% (nZ5) respectively.
Protein concentration
Total protein concentration of each sample was determined by the Bio-Rad protein assay (Bio-Rad Laboratories) using Stanbio total protein standard (Fisher Scientific) . Protein concentration was used to normalize steroid values.
Morphology assessment
Tissue was paraffin embedded, sectioned at a thickness of 5 mm and stained with hematoxylin and eosin. Five different tubule cross sections from each region (efferent duct, caput, corpus, and cauda) of each animal were photographed using a QImaging Micropublisher 3.3 digital camera and QCapture Pro software (QImaging Corporation, Burnaby, BC, Canada). Images of each tubule cross section were measured for tubule diameter, lumen diameter, and epithelial height. Tubule and lumen diameter were measured in two different places within each cross section, and epithelial height was measured in five different places within each cross section and averaged.
Immunocytochemistry
The localization of ERa, ERb, and AR in the efferent duct, caput, corpus, and cauda was investigated by ICC . Tissue was paraffin embedded and sectioned at a thickness of 5 mm. Antigen retrieval was performed by placing slides in Coplin jars in a steamer and heating to 93 8C for AR and ERb. Slides were kept at 93 8C for 5 min and then allowed to cool to room temperature. ICC for ERa was performed on sections without antigen retrieval. Tissues were incubated overnight at 4 8C with rabbit anti-human AR (1:1000; Santa Cruz Biotechnology, Santa Cruz, CA, USA) or mouse anti-human ERb (1:40; Serotec, Raleigh, NC, USA), or for 2 h at room temperature with rabbit anti-mouse ERa (1:250; Santa Cruz Biotechnology). Following primary antibody incubation, sections were incubated with species appropriate biotinylated secondary antibody followed by an avidin-biotin-horseradish peroxidase complex (ABC reagent). Immunostaining was visualized using 3-amino-9-ethylcarbazol (AEC; AR and ERa) or 3,3 0 -diamnobenzidine (DAB; ERb) chromagen and evaluated by light microscopy. Sections of each region incubated with normal rabbit serum (NRS; AR and ERa) or mouse IgG (ERb) instead of primary antibody were used as negative controls.
mRNA analysis
To confirm the results of ICC, quantification of mRNA for ERa, ERb, and AR in the efferent duct and epididymis in 2-and 8-month boars was performed using Taqman PCR at the Lucy Whittier Molecular and Diagnostic Core Facility (University of California, Davis, CA, USA). For each receptor gene, final quantification was done using the comparative CT method (User Bulletin #2, Applied Biosystems, Foster City, CA, USA) and is reported as the n-fold difference relative to a calibrator (average value of control boars). The housekeeping gene GAPDH was used to normalize the CT values of each target gene. Final values for ERa, ERb, and AR mRNA in Letrozole-treated boars are n-fold different from control boars.
Western blotting
To verify if differences in ERa mRNA correlated with ERa protein in the efferent ducts, protein levels of ERa in the efferent ducts of 8-month animals (nZ4 pairs) were determined. Solubilized proteins from homogenized efferent ducts were separated on a SDS-polyacrylamide gel with a Hoefer Mighty Small II System (GE Healthcare; Piscataway, NJ, USA) using Multi Mark molecular weight standards (Invitrogen) and transferred to an Immobilon-P membrane (Millipore, Bedford, MA, USA). Membranes were incubated with normal donkey serum (Animal Science Horse Barn, UC Davis, CA, USA) for 1 h to block non-specific binding followed by primary antibody (ERa, 1:200; actin, 1:1500, Santa Cruz Biotechnology) incubation overnight at 4 8C. The next day, membranes were washed and incubated for 1 h with horse-radish peroxidase conjugated donkey anti-rabbit secondary antibody (Jackson Immunoresearch, West Grove, PA, USA). Bound antibody was visualized with chemiluminescence (Western Lightning; Perkin-Elmer) and exposed on SuperRx film (Fisher Scientific) .
Statistical analysis
All analyses were performed using the Mixed Models procedure of SAS (SAS version 9.1; Cary, NC, USA). The residuals were tested for normality and the data was normally distributed after natural log transformation. ANOVA were performed on the transformed data, which included main effects for age, region, and treatment. The effect of boar was considered a random effect to account for variation among animals. Comparisons were analyzed using the Tukey-Kramer multiple comparison test. Values are reported as least-squares meansGpooled S.E.M.
